John BARTLETT

Person

Toronto, CA

People

Patents Grantslast 30 patents

Information Patent Grant
Gene signature of residual risk following endocrine treatment in ea...
- Patent number 11,566,292
- Issue date Jan 31, 2023
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- Jane Bayani
- G01 - MEASURING TESTING
Information Patent Grant
Methods and devices for predicting anthracycline treatment efficacy
- Patent number 11,214,836
- Issue date Jan 4, 2022
- Ontario Institute for Cancer Research
- Melanie Spears
- G01 - MEASURING TESTING
Information Patent Grant
Targeting the histone pathway to detect and overcome anthracyclin r...
- Patent number 11,015,226
- Issue date May 25, 2021
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- Melanie Spears
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MOLECULAR CLASSIFIERS FOR PROSTATE CANCER
- Publication number 20230105654
- Publication date Apr 6, 2023
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- John BARTLETT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Gene Signature of Residual Risk Following Endocrine Treatment in Ea...
- Publication number 20190010553
- Publication date Jan 10, 2019
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- Jane Bayani
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Targeting the Histone Pathway to Detect and Overcome Anthracyclin R...
- Publication number 20180282819
- Publication date Oct 4, 2018
- ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
- Melanie Spears
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Systems, Devices and Methods for Constructing and Using a Biomarker
- Publication number 20170218456
- Publication date Aug 3, 2017
- ONTARIO INSTITUTE FOR CANCER RESEARCH
- John Bartlett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND DEVICES FOR PREDICTING ANTHRACYCLINE TREATMENT EFFICACY
- Publication number 20170175204
- Publication date Jun 22, 2017
- ONTARIO INSTITUTE FOR CANCER RESEARCH
- Melanie SPEARS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

John BARTLETT

Person

Patents Grantslast 30 patents

Gene signature of residual risk following endocrine treatment in ea...

Methods and devices for predicting anthracycline treatment efficacy

Targeting the histone pathway to detect and overcome anthracyclin r...

Patents Applicationslast 30 patents

MOLECULAR CLASSIFIERS FOR PROSTATE CANCER

Gene Signature of Residual Risk Following Endocrine Treatment in Ea...

Targeting the Histone Pathway to Detect and Overcome Anthracyclin R...

Systems, Devices and Methods for Constructing and Using a Biomarker

METHODS AND DEVICES FOR PREDICTING ANTHRACYCLINE TREATMENT EFFICACY